Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdds a recruitment status note and new user-help navigation items (How to Read a Study Record, Common Questions, How to Join a Study). Also updates the Intervention header to Intervention/Treatment and adds a Revision: v3.6.0 note, reflecting formatting and version updates rather than substantive trial data.SummaryDifference0.2%

- Check17 days agoChange Detected- Page revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page.SummaryDifference0.0%

- Check38 days agoChange DetectedVersion update from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation/system rather than a substantive change to study content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision metadata was updated from v3.5.2 to v3.5.3 on the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedNapoli, Italy, 80131 has been changed to Naples, Italy, 80131. The revision label has been updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.